FDA Documents of Daiichi Sankyo Chemical Pharma Co., Ltd.
Daiichi Sankyo Chemical Pharma Co., Ltd. is an organization that has been audited by the FDA 13 times between 2001 and 2023 across all 6 sites.
Documents
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Iwaki | 2023
Out-of-stock
Issued on: Dec 22, 2023
Human Drugs Form 483
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Iwaki | 2021
Out-of-stock
Issued on: Jul 9, 2021
Human Drug Form 483
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Odawara | 2019
Out-of-stock
Issued on: Jan 25, 2019
Human Drug Form 483
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Odawara | 2016
Out-of-stock
Issued on: Apr 15, 2016
Human Drug Form 483
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Odawara | 2014
Out-of-stock
Issued on: Jun 20, 2014
Human Drug Form 483
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Hiratsuka, Shi, Kanagawa | 2007
Out-of-stock
Issued on: Mar 14, 2007
Human Drug Form 483
FDA 483 Daiichi Sankyo Chemical Pharma Co., Ltd., Hiratsuka, Shi, Kanagawa | 2005
Out-of-stock
Issued on: Jan 25, 2005
Human Drug Form 483
FDA Investigators(14)
- Jolanna A. Norton, FDA Investigator
- Thuy T. Nguyen, FDA Investigator
- Veronica Fuentes, FDA Investigator
- Viviana Matta, FDA Investigator
- Zachary L. Stamm, FDA Investigator
- Dennis Cantellops Paite, FDA Investigator
- Cantellops Paite, Dennis, FDA Investigator
- Thao T. Kwan, FDA Investigator
- Alberto A. Viciedo, FDA Investigator
- Joey V. Quitania, FDA Investigator
- Kim L. Thomas Cruse, FDA Investigator
- Thomas Cruse, Kim L, FDA Investigator
- Raymond T. Oji, FDA Investigator
- Charles I. Ahn, FDA Investigator